Syntal Capital Partners’s Merck MRK Stock Holding History

Syntal Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,560	Closed	-$1.24M	–	120
2023 Q1	$1.24M	Sell	11,560 -16,416	-59%	-$1.77M	0.45%	71
2022 Q4	$3.12M	Sell	27,976 -196	-0.7%	-$20K	1.24%	17
2022 Q3	$2.44M	Buy	28,172 +347	+1%	+$31K	1%	19
2022 Q2	$2.54M	Buy	+27,825	New	+$2.47M	1.13%	18
2019 Q3	–	Sell	-7,284	Closed	-$582K	–	269
2019 Q2	$582K	Sell	7,284 -800	-10%	-$61.3K	0.13%	147
2019 Q1	$641K	Buy	+8,084	New	+$605K	0.29%	59
2015 Q2	–	Sell	-157	Closed	-$8K	–	179
2015 Q1	$8K	Buy	+157	New	+$8.89K	0.01%	165
2014 Q4	–	Sell	-157	Closed	-$8K	–	189
2014 Q3	$8K	Hold	157	–	–	﹤0.01%	185
2014 Q2	$8K	Buy	+157	New	+$8.56K	﹤0.01%	204

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Syntal Capital Partners's MRK Position: Q2 2023 in Review

Syntal Capital Partners sold out of Merck (MRK) in Q2 2023, closing a stake of 11,560 shares — an estimated $1.24M sold.

Syntal Capital Partners first reported a position in MRK in Q2 2014 and held it in 9 quarters. The position peaked at $3.12M in Q4 2022. 3,256 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

Syntal Capital Partners reported no remaining Merck position as of Q2 2023 after selling out during the quarter.
Syntal Capital Partners sold 11,560 Merck shares in Q2 2023, an estimated $1.24M.
Syntal Capital Partners first reported a position in Merck in Q2 2014 and held it in 9 quarters.
Syntal Capital Partners's Merck position peaked at $3.12M in Q4 2022.
3,256 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on Syntal Capital Partners's 13F filing for Q2 2023, filed 7 Aug 2023.